MBAI
Check-Cap Ltd.
NASDAQ: MBAI · HEALTHCARE · DIAGNOSTICS & RESEARCH
$1.06
-0.93% today
Updated 2026-07-31
Market cap
$8.27M
P/E ratio
1.62
P/S ratio
—
EPS (TTM)
$0.66
Dividend yield
—
52W range
$1 – $4
Volume
0.1M
WallStSmart proprietary scores
31
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C4.5
Quality
C5.0
Profitability
C+6.7
Valuation
B2/9
Piotroski F-Score
Weak
-29.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →207 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ ROE 120.45% — strong efficiency
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -29.22 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-46000.00
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-19.11M | $-17.57M | $-25.15M | $4.14M | $4.14M |
| EPS | — | — | — | — | $0.66 |
| Free cash flow | $-19.19M | $-17.04M | $-8.00M | $-46000.00 | $-46000.00 |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Check-Cap Ltd. trades at $1.06. representing a P/E of 1.62x trailing earnings. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -29.22, it sits in the distress.
Frequently asked questions
What is Check-Cap Ltd.'s stock price?
Check-Cap Ltd. (MBAI) trades at $1.06, on a P/E of 1.6x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Check-Cap Ltd. overvalued?
Check-Cap Ltd. carries a Smart Value Score of 31/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
Altman Z-Score?
Check-Cap Ltd.'s Altman Z-Score is -29.22, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE120.45%
Beta0.79
50D MA$1.39
200D MA$1.61
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—